Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMA Tackles Complexities Introduced By Literature Monitoring Service

Executive Summary

The European Medicines Agency is looking at ways to improve and simplify its medical literature monitoring service, which has created new complexities for the generics pharmaceutical industry.

Advertisement

Related Content

Roadmap On Improvements To EMA's Literature Monitoring Service Due By Year End
EMA Survey To Gauge Pharma's Satisfaction With Its Medical Literature Monitoring Service
EMA's Medical Literature Monitoring Service Creates New Complexities For Pharma
EMA to scour medical literature for potential safety concerns from popular drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS119080

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel